11. EP-1365: Dosimetric predictors for rectal toxicity with two hypofractionated schedules for prostate cancer. (April 2016) Authors: Zilli, T.; Kountouri, M.; Rouzaud, M.; Dubouloz, A.; Linero, D.; Jorcano, S.; Escudé, L.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. EP-1554 Twice vs thrice-weekly moderate hypofractionated EBRT for PCa: does overall treatment time matter?. (April 2019) Authors: Achard, V.; Jorcano, S.; Rouzaud, M.; Escude, L.; Miralbell, R.; Zilli, T. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. EP-1601 Radiotherapy in resectable Intrathoracic Sarcomas. A Rare Cancer Network Study. (April 2019) Authors: Solé, C.; Larsen, F.; Terlizzi, M.; Sargos, P.; Linacre, V.; Suarez, F.; Kirova, Y.; Van Houtte, P.; Lerouge, D.; Zilli, T. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. OC-0302: Endorectal balloon for prostate SBRT: dosimetric impact on erectile function preservation?. (April 2018) Authors: Lamanna, G.; Dubouloz, A.; Rouzaud, M.; Miralbell, R.; Zilli, T. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. OC-0503: Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial. (April 2018) Authors: Zilli, T.; Jorcano, S.; Bral, S.; Rubio, C.; Bruynzeel, A.; Oliveira, A.; Abacioglu, U.; Minn, H.; Symon, Z.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis. (May 2022) Authors: Guckenberger, M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Balermpas, P.; Livi, L.; Lievens, Y.; Braam, P.; Jereczek- Fossa, B.A.; Stellamans, K.; Ratosa, I.; Peulen, H.; Widder, J.; Ramella, S.; Verbeke, L.; Dirix, P.; Khanfir, K.; Zilli, T.; Hemmatazad, H.; Jeene, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity. (May 2022) Authors: Zilli, T.; Siva, S.; Heikkilä, R.; Dirix, P.; Liefhooghe, N.; Otte, F.; Gomez-Iturriaga, A.; Everaerts, W.; Shelan, M.; Conde- Moreno, A.; López Campos, F.; Papachristofilou, A.; Guckenberger, M.; Scorsetti, M.; Zapatero, A.; Villafranca Iturre, A.; Eito, C.; Couñago, F.; Muto, P.; Van De Voorde, L. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. OC-0607 Radiotherapy guided by functional imaging for macroscopic local recurrence following prostatectomy. (May 2022) Authors: Benziane, N.; Sargos, P.; Zilli, T.; Giraud, A.; Ingrosso, G.; Di Staso, M.; Trippa, F.; Meyer, E.; Francolini, G.; Schick, U.; Cosset, J.M.; Martin, E.; Ferrari, V.; Achard, V.; Giraud, N.; Pasquier, C.; Magné, N.; Pasquier, D.; Supiot, S.; Latorzeff, I. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. OC-0609 Radiotherapy quality assurance of the PEACE-1 trial: Initial results of individual case reviews. (May 2022) Authors: Alyamani, N.; Sargos, P.; Blanchard, P.; Supiot, S.; Ronchin, P.; Pommier, P.; Duberge, T.; Silva, M.; Hammoud, Y.; Hasbini, A.; Khalifa, J.; Gnep, K.; Scrase, C.; Saez, J.; Vieillevigne, L.; Christiaens, M.; Zilli, T.; Ribault, H.; Bossi, A.; Fizazi, K. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. OC-0609 Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial. (April 2019) Authors: Jaccard, M.; Zilli, T.; Dubouloz, A.; Tsang, L.; Zvi, S.; Linthout, N.; Bral, S.; Verbakel, W.; Bruynzeel, A.; Björkqvist, M.; Minn, H.; Escude, L.; Jorcano, S.; Lencart, J.; Oliveira, A.; Ozen, Z.; Abacioglu, U.; Pérez-Moreno, J.M.; Rubio, C.; Rouzaud, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗